Search

everythinglearnresearchcommunity

for

Search:↓

Hirsutism is a strong sign of high male hormones and metabolic problems in women with PCOS, but acne and hair loss are not.

High levels of male hormones in women without tumors are linked to metabolic problems and can be treated with metformin.

Male mice with FGF5 mutations grow longer hair than females.

Too much prolactin can cause menstrual problems, infertility, and sexual issues in women.

Certain hormone treatments can improve acne and related conditions in women.

Hirsutism in women is often due to hormone sensitivity and has significant psychological effects.

Understanding sex and gender differences can improve personalized dermatology care.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Hormone replacement therapy may lower the risk of severe COVID-19 outcomes in non-immunosuppressed people and male organ transplant recipients.

Acne severity in women may not be linked to increased male hormone indicators like excess body hair, menstrual irregularities, or hair loss.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Hormone levels in hair change during pregnancy, with progesterone increasing significantly compared to non-pregnant women.

Combining Traditional Chinese Medicine and Western medicine can improve symptoms, hormone levels, and pregnancy outcomes in Polycystic Ovary Syndrome patients, but more research is needed.

Insulin resistance contributes to hormone imbalances in many women with polycystic ovary syndrome.

Lifestyle changes are the main treatment for PCOS, which is a complex condition requiring early management to reduce its health impacts.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

The conclusion is that while oral contraceptive pills are effective for PCOS-related high androgen levels, new treatments with fewer side effects are needed.

Eating healthy, exercising, and changing behaviors are the best first steps to treat Polycystic Ovary Syndrome (PCOS).

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Longer anogenital distance may indicate a higher chance of having polycystic ovary syndrome, and measuring this distance along with hormone levels could improve diagnosis.

Hair analysis can somewhat track past testosterone levels but is influenced by factors like hair washing, growth rate, sex, and hair color.

Low-dose finasteride effectively reduces hirsutism without serious side-effects.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Different drugs can treat high male hormone levels in women, but they have various effects and some may harm a fetus.

A new gene mutation causes complete androgen insensitivity in a 16-year-old with a female appearance.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

GnRH agonist effectively diagnoses and treats postmenopausal hyperandrogenism from ovarian sources.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Hormonal therapy changes skin and hair in transgender patients, who need better researched dermatologic care.